Skip to main navigation Skip to search Skip to main content

Chemoprevention of cancer: Lessons to be learned from beta-carotene trials

  • Karolinska Institutet

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

Observational studies indicate a lower incidence of chronic diseases, including various cancers and cardiovascular disease, related to higher intakes of carotenoid containing foods (fruits and vegetables). Beta-carotene, one of the large number of naturally occurring carotenoids, thus appears to actively participate in health. However, recent intervention trials indicate that beta-carotene supplements are not efficacious in the prevention of cardiovascular disease and major cancers occurring in well-nourished populations. In fact, supplemental beta-carotene appears to increase, rather than to reduce, lung cancer incidence and deaths from cardiovascular disease in current smokers and in asbestos exposed workers. In order to resolve these paradoxes, we need to better understand the underlying biology, identify interactions, develop mechanistic hypotheses and test them in clinical trials in humans. Until that time, we should confine any premature enthusiasm for chemopreventive supplementation. Copyright (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)513-517
Number of pages5
JournalToxicology Letters
Volume112-113
DOIs
StatePublished - 15 Mar 2000
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cancer
  • Carotenoids
  • Chemoprevention
  • Intervention

Fingerprint

Dive into the research topics of 'Chemoprevention of cancer: Lessons to be learned from beta-carotene trials'. Together they form a unique fingerprint.

Cite this